Imaging in the Causes of Secondary Hypertension: Unveiling the Hidden Culprits

Abstract

Secondary hypertension refers to the cases of hypertension having a specific underlying etiology. Secondary hypertension can be further divided to endocrine or nonendocrine causes. Radiologists must accurately identify the secondary causes of hypertension, as many of them can be treated, and treatment can result in improved symptoms or resolution of hypertension. Secondary hypertension requires a thorough imaging investigation using ultrasound, Doppler ultrasound, computed tomography angiography, magnetic resonance imaging, scintigraphy, and other imaging techniques to identify the underlying cause for optimal management.

Keywords

secondary hypertension - endocrinological causes - nonendocrinological causes

Publikationsverlauf

Artikel online veröffentlicht:
11. März 2024

• References

• 1 Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD, Robertson JW. Secondary hypertension in a blood pressure clinic. Arch Intern Med 1987; 147 (07) 1289-1293
• 2 Anderson Jr GH, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 1994; 12 (05) 609-615
• 3 Taler SJ. Initial treatment of hypertension. N Engl J Med 2018; 378 (07) 636-644
• 4 Sica DA. Endocrine causes of secondary hypertension. J Clin Hypertens (Greenwich) 2008; 10 (07) 534-540
• 5 Gupta-Malhotra M, Banker A, Shete S. et al. Essential hypertension vs. secondary hypertension among children. Am J Hypertens 2015; 28 (01) 73-80
• 6 Lattin Jr GE, Sturgill ED, Tujo CA. et al. From the radiologic pathology archives: Adrenal tumors and tumor-like conditions in the adult: radiologic-pathologic correlation. Radiographics 2014; 34 (03) 805-829
• 7 Johnson PT, Horton KM, Fishman EK. Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics 2009; 29 (05) 1333-1351
• 8 Shetty AS, Sipe AL, Zulfiqar M. et al. In-phase and opposed-phase imaging: applications of chemical shift and magnetic susceptibility in the chest and abdomen. Radiographics 2019; 39 (01) 115-135
• 9 Young Jr WF, Calhoun DA, Lenders JW, Stowasser M, Textor SC. Screening for endocrine hypertension: an endocrine Society scientific statement. Endocr Rev 2017; 38 (02) 103-122
• 10 Wagner-Bartak NA, Baiomy A, Habra MA. et al. Cushing syndrome: diagnostic workup and imaging features, with clinical and pathologic correlation. AJR Am J Roentgenol 2017; 209 (01) 19-32
• 11 Gardeur D. New Protocol for the MR Imaging of Pituitary Adenomas. Multiphase, Dynamic and Volumetric Imaging on MAGNETOM Skyra The Importance of StarVIBE and CAIPIRINHA Sequences. Siemens.Siemens MRI.
• 12 Plouin PF, Fitzgerald P, Rich T. et al. Metastatic pheochromocytoma and paraganglioma: focus on therapeutics. Horm Metab Res 2012; 44 (05) 390-399
• 13 Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL. Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst 2003; 95 (16) 1196-1204
• 14 Blake MA, Kalra MK, Maher MM. et al. Pheochromocytoma: an imaging chameleon. Radiographics 2004; 24 (Suppl. 01) S87-S99
• 15 Das CJ, Baruah MP, Baruah UM. Radiological imaging in endocrine hypertension. Indian J Endocrinol Metab 2011; 15 (Suppl. 04) S383-S388
• 16 Patel CN, Scarsbrook AF. Multimodality imaging in hyperparathyroidism. Postgrad Med J 2009; 85 (1009) 597-605
• 17 Prisant LM, Mawulawde K, Kapoor D, Joe C. Coarctation of the aorta: a secondary cause of hypertension. J Clin Hypertens (Greenwich) 2004; 6 (06) 347-350 , 352
• 18 Herrmann SM, Textor SC. Current concepts in the treatment of renovascular hypertension. Am J Hypertens 2018; 31 (02) 139-149
• 19 Li JC, Wang L, Jiang YX. et al. Evaluation of renal artery stenosis with velocity parameters of Doppler sonography. J Ultrasound Med 2006; 25 (06) 735-742 , quiz 743–744
• 20 House MK, Dowling RJ, King P, Gibson RN. Using Doppler sonography to reveal renal artery stenosis: an evaluation of optimal imaging parameters. AJR Am J Roentgenol 1999; 173 (03) 761-765
• 21 Granata A, Fiorini F, Andrulli S. et al. Doppler ultrasound and renal artery stenosis: an overview. J Ultrasound 2009; 12 (04) 133-143
• 22 Voiculescu A, Schmitz M, Plum J. et al. Duplex ultrasound and renin ratio predict treatment failure after revascularization for renal artery stenosis. Am J Hypertens 2006; 19 (07) 756-763
• 23 Leung DA, Hoffmann U, Pfammatter T. et al. Magnetic resonance angiography versus duplex sonography for diagnosing renovascular disease. Hypertension 1999; 33 (02) 726-731
• 24 Lewis III VD, Meranze SG, McLean GK, O'Neill Jr JA, Berkowitz HD, Burke DR. The midaortic syndrome: diagnosis and treatment. Radiology 1988; 167 (01) 111-113
• 25 Yan L, Li H-Y, Ye X-J, Xu RQ, Chen XY. Doppler ultrasonographic and clinical features of middle aortic syndrome. J Clin Ultrasound 2019; 47 (01) 22-26
• 26 Ihm CG. Hypertension in chronic glomerulonephritis. Electrolyte Blood Press 2015; 13 (02) 41-45
• 27 Campese VM, Mitra N, Sandee D. Hypertension in renal parenchymal disease: why is it so resistant to treatment?. Kidney Int 2006; 69 (06) 967-973
• 28 Smyth A, Collins CS, Thorsteinsdottir B. et al. Page kidney: etiology, renal function outcomes and risk for future hypertension. J Clin Hypertens (Greenwich) 2012; 14 (04) 216-221